Novo Nordisk A/S investors got a much-needed boost from last week’s trial results for an experimental weight-loss shot. But ...

It’s a problem that has plagued European governments for decades, from the credit-crunch bank bailouts of 2008 to more recent ...

Drug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight ...

The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various ...

Analysts predict the weight loss drug market to grow between $100 billion and $130 billion by 2030, as per a report.

Novo Nordisk has such a blockbuster with Wegovy ... For more on the business and cultural impact of new weight loss drugs, see our special series The Obesity Revolution.

We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

Since the launch of The Crossword in 1942, The Times has captivated solvers by providing engaging word and logic games. In 2014, we introduced The Mini Crossword — followed by Spelling Bee ...

Addressing a joint session of Parliament, signalling the start of the Budget session, Murmu said the government’s third term is witnessing work at "thrice the speed of previous administrations ...